LOGC
LogicBio Therapeutics Inc
Halal Rating :
Last Price
$6.87
Last updated:
Market Cap
-
7D Change
3.62%
1 Year Change
47.42%
Company Overview
Industries
Exchange
Next Earnings Date
LogicBio Therapeutics Inc was a genome editing company focused on developing medicines to treat rare diseases. However, in October 2022, the company was acquired by AstraZeneca for approximately $68 million. The company is no longer publicly traded as an independent entity.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $7.0m | $26.0m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $36.0m | $89.0m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate LogicBio Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.